BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32553697)

  • 1. Patient reported outcomes and quality of life in Chinese patients with implantable cardioverter defibrillators
    Guo X; Tripp C; Huber NL; Hou C; Lv R; Li J; Liang T; Sears SF
    Heart Lung; 2021; 50(1):153-158. PubMed ID: 32553697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
    Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
    J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life outcomes in chinese patients with implantable cardioverter defibrillators.
    Chair SY; Lee CK; Choi KC; Sears SF
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):858-67. PubMed ID: 21410723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
    Udlis KA
    J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease.
    Bedair R; Babu-Narayan SV; Dimopoulos K; Quyam S; Doyle AM; Swan L; Gatzoulis MA; Wong T
    Int J Cardiol; 2015 Feb; 181():218-24. PubMed ID: 25528316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and mental health predict early device-specific quality of life in patients receiving prophylactic implantable defibrillators.
    Carroll SL; Markle-Reid M; Ciliska D; Connolly SJ; Arthur HM
    Can J Cardiol; 2012; 28(4):502-7. PubMed ID: 22425267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, Sex, and Remote Monitoring Differences in Device Acceptance for Patients With Implanted Cardioverter Defibrillators in Canada.
    Ng J; Sears SF; Exner DV; Reyes L; Cravetchi X; Cassidy P; Morton J; Lohrenz C; Low A; Sandhu RK; Sheldon RS; Raj SR
    CJC Open; 2020 Nov; 2(6):483-489. PubMed ID: 33305207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey.
    Versteeg H; Starrenburg A; Denollet J; Palen Jv; Sears SF; Pedersen SS
    Pacing Clin Electrophysiol; 2012 Mar; 35(3):283-93. PubMed ID: 22229519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with health-related quality of life among cardiac arrest survivors treated with an implantable cardioverter-defibrillator.
    Israelsson J; Thylén I; Strömberg A; Bremer A; Årestedt K
    Resuscitation; 2018 Nov; 132():78-84. PubMed ID: 30201535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial.
    Versteeg H; Timmermans I; Widdershoven J; Kimman GJ; Prevot S; Rauwolf T; Scholten MF; Zitron E; Mabo P; Denollet J; Pedersen SS; Meine M
    Europace; 2019 Sep; 21(9):1360-1368. PubMed ID: 31168604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shock-related anxiety and sexual function in adults with congenital heart disease and implantable cardioverter-defibrillators.
    Cook SC; Valente AM; Maul TM; Dew MA; Hickey J; Jennifer Burger P; Harmon A; Clair M; Webster G; Cecchin F; Khairy P;
    Heart Rhythm; 2013 Jun; 10(6):805-10. PubMed ID: 23422223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Florida Shock Anxiety Scale (FSAS) for patients with implantable cardioverter defibrillators: testing factor structure, reliability, and validity of a previously established measure.
    Ford J; Finch JF; Woodrow LK; Cutitta KE; Shea J; Fischer A; Hazelton G; Sears SF
    Pacing Clin Electrophysiol; 2012 Sep; 35(9):1146-53. PubMed ID: 22758923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported quality of life and acceptance of the extravascular implantable cardioverter-defibrillator: Results from pivotal study.
    Sears SF; Harrell R; Crozier I; Murgatroyd F; Boersma LVA; Manlucu J; Knight BP; Leclercq C; Birgersdotter-Green UM; Wiggenhorn C; Hilleren G; Friedman P
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):240-246. PubMed ID: 38047465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey.
    Burns JL; Serber ER; Keim S; Sears SF
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):384-90. PubMed ID: 15828880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
    James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
    Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring ICD shock anxiety: Status update on the Florida Shock Anxiety Scale after over a decade of use.
    Tripp C; Huber NL; Kuhl EA; Sears SF
    Pacing Clin Electrophysiol; 2019 Oct; 42(10):1294-1301. PubMed ID: 31463949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective survey of implantable defibrillator shock anxiety in Japanese patients: Results from the DEF-Chiba study.
    Miyazawa K; Kondo Y; Ueda M; Kajiyama T; Nakano M; Inagaki M; Schwab JO; Sears SF; Kobayashi Y
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1171-1177. PubMed ID: 29987847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial.
    Sears SF; Rosman L; Sasaki S; Kondo Y; Sterns LD; Schloss EJ; Kurita T; Meijer A; Raijmakers J; Gerritse B; Auricchio A
    Heart Rhythm; 2018 May; 15(5):734-740. PubMed ID: 29277687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both mental and physical health predicts one year mortality and readmissions in patients with implantable cardioverter defibrillators: findings from the national DenHeart study.
    Berg SK; Rasmussen TB; Mols RE; Thorup CB; Borregaard B; Christensen AV; Cromhout PF; Ekholm O; Juel K; Thrysoee L
    Eur J Cardiovasc Nurs; 2019 Feb; 18(2):96-105. PubMed ID: 30114937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing a nurse-led, pre-implantation educational intervention for primary prevention implantable cardioverter-defibrillator candidates: a randomized feasibility trial.
    Pannag J; Martin L; Yost J; McGillion M; Carroll SL
    Eur J Cardiovasc Nurs; 2021 May; 20(4):367-375. PubMed ID: 33620480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.